UNSPSC 51391601: Octodrine

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3GQ9E911BI, chemically known as 1,5-dimethylhexylamine but generally known as octodrine, which bears US NIH Compound Identifier 10982. European Medicines Agency schedules Octodrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09414MIG.

UNSPSC 51391601 Octodrine is a Commodity code that, based on recent state and local solicitations, encompasses the procurement of pharmaceutical products and related health-support systems for community health and pharmacy benefit initiatives. State and local governments are using this code to source naloxone products, drug deactivation systems, and direct-to-manufacturer prescription fulfillment services that support opioid response and pharmacy benefit management. The issuing bodies soliciting under this code include county health departments and state health and human services agencies. Seminole County, Florida and the Texas Health and Human Services Commission are among the recent active buyers, indicating activity across both county-level public health and state-level pharmacy benefit administration.

Recent opportunities reflect two distinct work streams: Seminole County issued an IFB (Solicitation IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to its Community Health Building, with responses due July 26, 2023. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013) on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on direct contracting models, volume fulfillment strategies, and outcomes-based agreements outside traditional pharmacy benefit manager and group purchasing organization channels. Activity is concentrated in Florida and Texas, with procurement spanning both commodity purchase (naloxone and drug deactivation systems) and services (prescription fulfillment strategy and direct-to-manufacturer contracting).